ANDA 83997, held by Altana. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83997 (Zipan-25, Zipan-50), held by Altana, was first approved by FDA on Nov 21, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 1978 | Original application | Approved | None posted |
| Zipan-2525MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
| Zipan-5050MG/ML · injectable;injection | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters